Gilead Sciences, Inc. (GILD) announced the company now expects EPS Impact of acquisition-related, up-front collaboration, stock-based compensation and other expenses to be in the range of $1.47 - $1.53 for the full year 2016, up from the previously projected range of $1.10 - $1.16.
from RTT - Earnings http://ift.tt/2apKNax
via IFTTT
No comments:
Post a Comment